Cargando…

The Feasibility of Using N-Of-1 Trials to Investigate Deprescribing in Older Adults with Dementia: A Pilot Study

N-of-1 trials may provide insights into the impact of deprescribing medications in populations where evidence is currently lacking, such as the effect of statins on cognition in people with dementia. For this pilot, N-of-1, double-blinded, deprescribing trial, adults over 80 years of age with dement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clough, Alexander J., Hilmer, Sarah N., Naismith, Sharon L., Gnjidic, Danijela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955788/ https://www.ncbi.nlm.nih.gov/pubmed/31842475 http://dx.doi.org/10.3390/healthcare7040161

Ejemplares similares

Health professionals’ and researchers’ opinions on conducting clinical deprescribing trials
por: Clough, Alexander J., et al.
Publicado: (2019)

Preferences for deprescribing antihypertensive medications amongst clinicians, carers and people living with dementia: a discrete choice experiment
por: Raghunandan, Rakhee, et al.
Publicado: (2023)

Development of consumer information leaflets for deprescribing in older hospital inpatients: a mixed-methods study
por: Jokanovic, Natali, et al.
Publicado: (2019)

Integration of an electronic Drug Burden Index risk assessment tool into Home Medicines Reviews: deprescribing anticholinergic and sedative medications
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2019)

The impact of in hospital patient-education intervention on older people’s attitudes and intention to have their benzodiazepines deprescribed: a feasibility study
por: Gnjidic, Danijela, et al.
Publicado: (2019)

Drug Burden Index in older adults: theoretical and practical issues
por: Kouladjian, Lisa, et al.
Publicado: (2014)

Impact of a Comprehensive Intervention Bundle Including the Drug Burden Index on Deprescribing Anticholinergic and Sedative Drugs in Older Acute Inpatients: A Non-randomised Controlled Before-and-After Pilot Study
por: Fujita, Kenji, et al.
Publicado: (2023)

Deprescribing in the Older Patient: A Narrative Review of Challenges and Solutions
por: Wu, Harry, et al.
Publicado: (2021)

The anticholinergic burden: from research to practice
por: Hilmer, Sarah N, et al.
Publicado: (2022)

Caregivers’ Perspectives of Medication Management Advice for People With Dementia at Hospital Discharge
por: Sawan, Mouna, et al.
Publicado: (2020)

Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community
por: Bergler, Ulrich, et al.
Publicado: (2021)

BURDEN OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG OLDER VETERANS WITH PAIN AND DEMENTIA
por: Allore, Heather, et al.
Publicado: (2019)

Establishing the worth of deprescribing inappropriate medications: are we there yet?
por: Scott, Ian A, et al.
Publicado: (2022)

Ethical Aspects of Physician Decision-Making for Deprescribing Among Older Adults With Dementia
por: Norton, Jonathan D., et al.
Publicado: (2023)

The Prevalence of Adverse Drug Reactions and Adverse Drug Events from Heart Failure Medications in Frail Older Adults: A Systematic Review
por: Duong, Mai H., et al.
Publicado: (2022)

Deprescribing Anticholinergic and Sedative Drugs to Reduce Polypharmacy in Frail Older Adults Living in the Community: A Randomized Controlled Trial
por: Jamieson, Hamish, et al.
Publicado: (2023)

Deprescribing in older people
por: Liacos, Michelle, et al.
Publicado: (2020)

Development of a tool to evaluate medication management guidance provided to carers of people living with dementia at hospital discharge: a mixed methods study
por: Sawan, Mouna J, et al.
Publicado: (2022)

Comparing Effects of Polypharmacy on Inflammatory Profiles in Older Adults and Mice: Implications for Translational Aging Research
por: Wu, Harry, et al.
Publicado: (2022)

Correction to: Implementation of the goal-directed medication review electronic decision support system (G-MEDSS)© into home medicines review: a protocol for a clusterrandomised clinical trial in older adults
por: O’Donnell, Lisa Kouladjian, et al.
Publicado: (2020)

Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults
por: Kouladjian O’Donnell, Lisa, et al.
Publicado: (2020)

Impact of High Risk Drug Use on Hospitalization and Mortality in Older People with and without Alzheimer’s Disease: A National Population Cohort Study
por: Gnjidic, Danijela, et al.
Publicado: (2014)

Consumer Attitudes Towards Deprescribing: A Systematic Review and Meta-Analysis
por: Weir, Kristie Rebecca, et al.
Publicado: (2021)

Antihypertensive Deprescribing in Older Adults: a Practical Guide
por: Sheppard, James P., et al.
Publicado: (2022)

High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level
por: Gnjidic, Danijela, et al.
Publicado: (2013)

Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation
por: Weir, Kristie Rebecca, et al.
Publicado: (2023)

Older Adults’ Awareness of Deprescribing: A Population‐Based Survey
por: Turner, Justin P., et al.
Publicado: (2017)

Potentially inappropriate medication and attitudes of older adults towards deprescribing
por: Achterhof, Alexandra B., et al.
Publicado: (2020)

Attitudes of ambulatory care older Nepalese patients towards deprescribing and predictors of their willingness to deprescribe
por: Shrestha, Shakti, et al.
Publicado: (2021)

Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices
por: Hassan, Dimokrat, et al.
Publicado: (2022)

Deprescribing Antipsychotics Based on Real-World Evidence to Inform Clinical Practice: Safety Considerations in Managing Older Adults with Dementia
por: Hsieh, Stephanie, et al.
Publicado: (2021)

Patterns of high-risk prescribing and other factors in relation to receipt of a home medicines review: a prospective cohort investigation among adults aged 45 years and over in Australia
por: Du, Wei, et al.
Publicado: (2019)

CCCDTD5 recommendations on the deprescribing of cognitive enhancers in dementia
por: Herrmann, Nathan, et al.
Publicado: (2022)

Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed
por: Reeve, Emily, et al.
Publicado: (2023)

Deprescribing to optimise health outcomes for frail older people: a double-blind placebo-controlled randomised controlled trial—outcomes of the Opti-med study
por: Etherton-Beer, Christopher, et al.
Publicado: (2023)

Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative
por: Carr, Frances, et al.
Publicado: (2019)

Implementation of an Opioid and Benzodiazepine Deprescribing Program for Older Adults in an Outpatient Setting
por: Armistead, Lori, et al.
Publicado: (2020)

Deprescribing in older adults during COVID-19 pandemic; Opportunity or risk?
por: Castelli, Letizia, et al.
Publicado: (2021)

A narrative review of evidence to guide deprescribing among older adults
por: Ie, Kenya, et al.
Publicado: (2021)

Primary-Care Prescribers’ Perspectives on Deprescribing Opioids and Benzodiazepines in Older Adults
por: Niznik, Joshua D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nh4ohcs5kra3n3gi95e77cqf37